We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.65%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.5M
AUM Growth
-$129M
Cap. Flow
+$5.75M
Cap. Flow %
7.23%
Top 10 Hldgs %
61.99%
Holding
120
New
40
Increased
18
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
SHIP icon
Seanergy Maritime Holdings
SHIP
+$3.88M
2
ATNM icon
Actinium Pharmaceuticals
ATNM
+$2.79M
3
SLS icon
SELLAS Life Sciences
SLS
+$2.79M
4
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.78M
5
RDGT
Ridgetech Inc
RDGT
+$2.6M

Top Sells

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.41M
2
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$2.28M
3
LOOP icon
Loop Industries
LOOP
+$1.97M
4
BIIB icon
Biogen
BIIB
+$1.62M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 36.62%
2 Industrials 1.78%
3 Technology 1.66%
4 Consumer Discretionary 1.42%
5 Real Estate 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
1
CALL
Ionis Pharmaceuticals
IONS
$9.14B
$17.8M 22.39%
2,771
+923
+50% +$65.2K
BIIB icon
2
CALL
Biogen
BIIB
$30.4B
$9.59M 12.06%
410
-1,893
-82% -$437K
ODT
3
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$4.88M 6.14%
133,105
-100,622
-43% -$2.41M
AMRN
4
PUT
Amarin Corp
AMRN
$293M
$4.86M 6.11%
+125
New +$45.8K
CRMD icon
5
PUT
CorMedix
CRMD
$577M
$2.57M 3.23%
4,633
-3,118
-40% -$24.5K
ATNM icon
6
Actinium Pharmaceuticals
ATNM
$27.2M
$2.05M 2.58%
+278,124
New +$2.79M
AMPE
7
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2.04M 2.57%
+17,551
New +$2.78M
RDGT
8
Ridgetech Inc
RDGT
$1.04M
$2.01M 2.53%
+51
New +$2.6M
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.94M 2.44%
+494,175
New +$2.58M
NMTR
10
DELISTED
9 Meters Biopharma
NMTR
$1.55M 1.95%
+66,812
New +$2M
SHIPW
11
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$1.54M 1.94%
+965,000
New +$29.7K
WVE icon
12
CALL
Wave Life Sciences
WVE
$1.13B
$1.44M 1.81%
552
-58
-10% -$1.63K
PAVMZ
13
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$1.37M 1.73%
3,270,329
-397,470
-11% -$159K
CRVO icon
14
CervoMed
CRVO
$23.7M
$1.34M 1.68%
+6,248
New +$1.68M
ORMP icon
15
Oramed Pharmaceuticals
ORMP
$171M
$1.27M 1.6%
354,713
-326,787
-48% -$1.15M
SOLO
16
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$1.13M 1.42%
452,796
-74,404
-14% -$220K
PHAS
17
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1.09M 1.37%
+82,931
New +$1.02M
SHIP icon
18
Seanergy Maritime Holdings
SHIP
$348M
$1.03M 1.3%
+10,437
New +$3.88M
PULM icon
19
Pulmatrix
PULM
$6.14M
$984K 1.24%
+53,360
New +$1.16M
ALBT
20
DELISTED
Avalon GloboCare
ALBT
$889K 1.12%
+2,279
New +$1.03M
GNPX icon
21
Genprex
GNPX
$4.05M
$798K 1%
15
+2
+15% +$144K
AVEO
22
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$744K 0.94%
+521
New +$4.46K
RNTX
23
Rein Therapeutics
RNTX
$66.9M
$728K 0.92%
+50,557
New +$1.33M
CVM.WS
24
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$703K 0.88%
1,392
+1,080
+346% +$545K
BCLI
25
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$625K 0.79%
10,543
-39,137
-79% -$2.28M
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sabby Management held 120 positions worth $79.5M, down 62% from $208M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management deployed $5.75M of net new capital in Q2 2019, opening 40 new positions and adding to 18 existing holdings. Its largest new stake was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Odonate Therapeutics, Inc. Common Stock, an estimated $2.41M trimmed.

  • Sabby Management's largest Q2 2019 buy was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.
  • Sabby Management added most to Bridgeline Digital in Q2 2019, an estimated $625K increase.
  • Sabby Management's biggest Q2 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $2.41M.
  • Sabby Management fully exited Loop Industries in Q2 2019, selling an estimated $1.97M.
  • Sabby Management's ten largest holdings make up 62% of its $79.5M portfolio in Q2 2019.
  • Sabby Management opened 40 new positions and closed 32 in Q2 2019.
  • Sabby Management's portfolio value fell 62% quarter-over-quarter to $79.5M.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.